Victor A Gault Selected Research

gastric inhibitory polypeptide (3-42)

5/2012

Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor A Gault Research Topics

Disease

35	Insulin Resistance 01/2021 - 06/2003
32	Body Weight (Weight, Body) 01/2024 - 09/2004
32	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2002
26	Obesity 01/2021 - 11/2002
5	Alzheimer Disease (Alzheimer's Disease) 02/2012 - 04/2007
4	Inflammation (Inflammations) 01/2018 - 11/2014
3	Glucose Intolerance 01/2024 - 02/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 06/2008
3	Cognitive Dysfunction 01/2018 - 04/2007
2	Hypertrophy 12/2007 - 08/2005
1	Weight Loss (Weight Reduction) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Short Bowel Syndrome 01/2021
1	Body Weight Changes 01/2020
1	Neuroinflammatory Diseases 01/2018
1	Gliosis 01/2018
1	Amyloid Plaque 02/2012
1	Hyperplasia 08/2005
1	Overnutrition 10/2003
1	Diabetes Mellitus 11/2002

Drug/Important Bio-Agent (IBA)

44	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 02/2002
35	Insulin (Novolin)FDA Link 01/2024 - 11/2002
26	Peptides (Polypeptides)IBA 01/2020 - 11/2002
16	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2004
13	xenin 25 (xenin)IBA 01/2021 - 08/2012
12	Hormones (Hormone)IBA 01/2024 - 10/2003
10	gastric inhibitory polypeptide receptorIBA 01/2020 - 02/2002
9	Glucagon (Glukagon)FDA Link 01/2024 - 12/2003
7	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2016
7	IncretinsIBA 01/2018 - 12/2003
6	EnzymesIBA 01/2018 - 02/2002
6	Triglycerides (Triacylglycerol)IBA 01/2018 - 12/2007
6	Pro(3)- glucose-dependent insulinotropic polypeptideIBA 12/2007 - 02/2002
4	Exenatide (Byetta)FDA Link 01/2024 - 01/2018
4	Liraglutide FDA Link 01/2020 - 08/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 01/2004
3	dapagliflozinIBA 01/2020 - 09/2017
3	OxyntomodulinIBA 11/2014 - 12/2010
3	PalmitatesIBA 08/2012 - 11/2002
3	monomethoxypolyethylene glycol (MPEG)IBA 12/2010 - 06/2008
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 01/2020
2	LipidsIBA 01/2020 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2020
2	Amylases FDA Link 09/2018 - 01/2018
2	Neuroprotective AgentsIBA 01/2018 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 02/2012
2	AdiponectinIBA 02/2009 - 06/2008
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2007 - 04/2006
2	Amyloid beta-PeptidesIBA 06/2007 - 04/2007
2	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 09/2006 - 09/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2006 - 09/2005
1	methionine aminopeptidase 2IBA 01/2021
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Ala(2)- glucose-dependent insulinotropic polypeptideIBA 01/2020
1	AntibodiesIBA 01/2020
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020
1	GastrinsIBA 09/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	CholesterolIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 04/2016
1	8-hydroxyguanineIBA 11/2014
1	lixisenatideIBA 11/2014
1	Peptide FragmentsIBA 05/2014
1	AcidsIBA 06/2013
1	gastric inhibitory polypeptide (3-42)IBA 05/2012
1	Presenilin-1IBA 02/2012
1	Congo RedIBA 02/2012
1	Amyloid (Amyloid Fibrils)IBA 02/2012
1	ResistinIBA 02/2009
1	amyloid beta-protein (25-35)IBA 06/2008
1	CarbenoxoloneIBA 04/2008
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 04/2008
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 04/2008
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2007
1	Hyp(3)-palmitoylLys(16)- glucose-dependent insulinotropic polypeptideIBA 06/2007
1	Hyp(3)- glucose-dependent insulinotropic polypeptideIBA 06/2007
1	Free RadicalsIBA 04/2007
1	exendin (9-39)IBA 02/2007
1	BiguanidesIBA 10/2006
1	Metformin (Glucophage)FDA LinkGeneric 10/2006
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 10/2006
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 09/2006
1	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 09/2006
1	N-AcGIP(LysPAL37)IBA 04/2006
1	Cyclic AMP (AMP, Cyclic)IBA 01/2004
1	Insulin SecretagoguesIBA 01/2004

Therapy/Procedure

12	Therapeutics 01/2021 - 10/2003
3	Intraperitoneal Injections 12/2007 - 02/2006
3	Injections 06/2007 - 09/2005
1	Withholding Treatment 08/2005